Blog
Cogent Q1 Loss Wider Than Expected, Revenues Decline Y/Y
Cogent Communications Inc. CCOI reported soft first-quarter 2025 results, with the bottom and top lines missing the Zacks Consensus Estimate. The Washington, DC-based leading Internet service
Can BrightSpring Health Services, Inc. (BTSG) Run Higher on Rising Earnings Estimates?
BrightSpring Health Services, Inc. (BTSG) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend
Why BioCryst (BCRX) Might be Well Poised for a Surge
BioCryst Pharmaceuticals (BCRX) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might
Earnings Estimates Moving Higher for Sendas Distribuidora (ASAIY): Time to Buy?
Sendas Distribuidora S.A. Sponsored ADR (ASAIY) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately
Unpacking the High Stakes US-China AI Energy Race
The China-US Rivalry Heats Up Amid Trade War
If you flip to any major financial news channel recently, you’re likely to hear the latest in the trade war between the world’s two largest economies –
Mirum's Q1 Earnings Beat Estimates, 2025 Revenue View Raised
Mirum Pharmaceuticals MIRM incurred a loss of 30 cents per share in the first quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 39 cents. The company had reported a loss of 54
Will Bath & Body Works (BBWI) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Bath & Body Works (BBWI), which belongs to the
Will Gap (GAP) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Gap (GAP), which belongs to the Zacks Retail -
Will Workday (WDAY) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Workday (WDAY), which belongs to the Zacks
Why Urban Outfitters (URBN) is Poised to Beat Earnings Estimates Again
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Urban Outfitters (URBN), which belongs to the
Why Home Depot (HD) Could Beat Earnings Estimates Again
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Home Depot (HD), which belongs to the Zacks
Ares Capital Misses on Q1 Earnings: Should You Sell or Hold the Stock?
Ares Capital Corporation ARCC announced its first-quarter 2025 results on April 29, recording lower portfolio exits and gross commitments. The company’s top and bottom-line numbers lagged the Zacks
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand
QuidelOrtho Corporation QDEL delivered adjusted earnings per share (EPS) of 74 cents in first-quarter 2025, up 68.2% year over year. The figure topped the Zacks Consensus Estimate by 27.6%. (Find
Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y
Amarin Corporation AMRN reported a loss of 4 cents per share for the first quarter of 2025, which was significantly narrower than the Zacks Consensus Estimate of a loss of $1.12. The company had
INGN Stock Gains Following Q1 Earnings Beat, Revenues Up Y/Y
Inogen, Inc. INGN incurred an adjusted loss per share of 11 cents for first-quarter 2025, which was narrower than the adjusted loss per share of 45 cents in the year-ago period and the Zacks
Baidu Stock Trades 25% Below 52-Week High: Should You Buy the Dip?
Baidu, Inc. BIDU shares have gained 7.8% in the past month, above the Zacks Internet – Services industry’s 3.4% increase and the Zacks Computer and Technology sector’s rise of 4.5%. Despite this
All You Need to Know About Alexander's (ALX) Rating Upgrade to Strong Buy
Alexander's (ALX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one
Guaranty Bancshares (GNTY) Upgraded to Strong Buy: Here's What You Should Know
Guaranty Bancshares Inc. (GNTY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings
Acadian Asset Management (AAMI) Upgraded to Buy: What Does It Mean for the Stock?
Acadian Asset Management (AAMI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why
LifeStance Health Group (LFST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings
What Makes Veracyte (VCYT) a New Buy Stock
Veracyte (VCYT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices
Monro (MNRO) Upgraded to Strong Buy: What Does It Mean for the Stock?
Monro Muffler Brake (MNRO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces
Fidelity National (FIS) Upgraded to Buy: What Does It Mean for the Stock?
Fidelity National Information Services (FIS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
Dynavax Technologies (DVAX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings
Novo Nordisk (NVO) Upgraded to Buy: Here's What You Should Know
Novo Nordisk (NVO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one


